a.amankwah

TL2 Moderator · Tampere

Contributes reviews on supplier material. Based in Tampere.

Joined 19 October 2024 · last posted 3d

77 posts, newest first. Showing up to 150.

CJC-1295 with and without DAC: what the modification does Replied, post #122 · Compounds › Secretagogues & GH axis · 25 Jul 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Which categories are strict and which are relaxed, honestly Replied, post #38 · Start Here › Welcome · 22 Jul 2026 · 28 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #119 · Outcomes › Body composition · 21 Jul 2026 · 21 likes post #118 answers the question as asked. The question underneath it is different. Comparison to published data: the trials reported mean fat and lean mass changes.…
MS/MS sequence confirmation: what it costs and when it is worth it Replied, post #6 · marked as the solution · Analytics › Mass spectrometry · 18 Jul 2026 · 9 likes This follows post #3 rather than contradicting it. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to confirm identity and detect…
Seven-day rolling means and why weekly readings mislead Replied, post #45 · Outcomes › Progress reports · 17 Jul 2026 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #30 · Analytics › HPLC & UHPLC · 12 Jul 2026 · 9 likes Picking up post #27: that is the part I would want checked first. On integration: where the baseline is drawn matters more than most people realise. On a clean…
Documenting a supplier's response to a discrepancy Replied, post #29 · Sourcing › Vendor reports · 3 Jul 2026 · 7 likes post #28 answers the question as asked. The question underneath it is different. Dosing and purity: a vial that is 99% pure might contain 80% of its label claim if the…
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #34 · Compounds › Secretagogues & GH axis · 30 Jun 2026 · 11 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
Primary endpoint hierarchies and why order matters — one year on Replied, post #28 · Evidence › Trials · 28 Jun 2026 · 2 likes Intent-to-treat versus per-protocol: ITT includes everyone assigned regardless of whether they took the drug. Per-protocol includes only those who completed it as…
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #48 · Compounds › Secretagogues & GH axis · 24 Jun 2026 · 31 likes Tesamorelin has an approved indication in HIV-associated lipodystrophy. That is the only compound in this class with a registration-quality evidence base from a proper…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #13 · Analytics › Impurities & related substances · 20 Jun 2026 · 29 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
Trust level 3 requirements: a clarification — does this still hold? Replied, post #67 · Meta › Announcements · 19 Jun 2026 · 13 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #116 · Practice › Reconstitution · 18 Jun 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
What to include when your question involves a chromatogram — one year on Replied, post #33 · Start Here › How to Ask · 11 Jun 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #77 · Data & Tools › Datasets · 8 Jun 2026 · 0 likes I read post #75 twice before replying, because I had assumed the opposite. Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method)…
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #87 · Outcomes › Body composition · 1 Jun 2026 · 1 like post #86 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
Packaging that arrived damaged: documenting it properly Replied, post #11 · Sourcing › Logistics · 17 May 2026 · 0 likes post #10 answers the question as asked. The question underneath it is different. Declaring contents accurately: declaring accurately reduces intervention risk. A…
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #13 · Compounds › Tirzepatide · 1 May 2026 · 20 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
Transporting a vial for a weekend away — a second dataset Replied, post #32 · Practice › Storage & stability · 19 Apr 2026 · 17 likes I read post #30 twice before replying, because I had assumed the opposite. Beyond-use dating: the date after which a prepared solution should not be used. It is an…
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #13 · Compounds › Repair & healing peptides · 18 Apr 2026 · 16 likes On post #9 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
Vomiting: when it is expected and when it is a reason to stop — one year on Started this topic · Practice › Side effects · 23 Mar 2026 · 55 likes Vomiting: when it is expected and when it is a reason to stop — one year on Writing it up because I had to work it out twice and would rather nobody else did. Reporting…
Which fields on a certificate actually matter, ranked Replied, post #15 · Analytics › COA interpretation · 15 Mar 2026 · 0 likes When a document puts the specification in the result column, it has told you the release criterion, not the measurement. Those are different claims and the second is…
Research-use-only status: what it means legally and practically Replied, post #12 · Compounds › Other compounds · 9 Mar 2026 · 11 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #17 · Lounge › Introductions · 8 Mar 2026 · 1 like Say hello. No question required. Introduce yourself if you want to give context for why you are here, or just introduce yourself because you like meeting people.
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #5 · Compounds › Repair & healing peptides · 7 Mar 2026 · 20 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
Waist circumference technique and its repeatability Replied, post #58 · Outcomes › Progress reports · 2 Mar 2026 · 25 likes Longitudinal report with the method stated: same scale, same time of day, same conditions. A scale is a tool; use the same one each time. Consistency matters more than…
The most useful thing you learned here that was not the answer you came for Replied, post #24 · Lounge › Off topic · 2 Mar 2026 · 5 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #130 · Practice › Dosing & titration · 21 Feb 2026 · 0 likes I read post #128 twice before replying, because I had assumed the opposite. Reaching a dose and staying there for a year: the question of whether a stable dose remains…
Guidelines revision: what changed and why — one year on Replied, post #73 · Meta › Announcements · 20 Feb 2026 · 22 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
Injection discomfort: needle gauge, volume, temperature, technique Replied, post #24 · Practice › Administration · 9 Feb 2026 · 31 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #10 · Evidence › Trials · 18 Jan 2026 · 16 likes Picking up post #7: that is the part I would want checked first. Dropout is information: high dropout rates can indicate tolerability problems or lower efficacy than…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #11 · Analytics › COA interpretation · 14 Jan 2026 · 32 likes This follows post #8 rather than contradicting it. Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide…
Amylin receptor signalling and satiety — what changed since Replied, post #15 · Pharmacology › Receptor biology · 12 Jan 2026 · 8 likes Worth separating two things that post #11 runs together. Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over…
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #52 · Access › Pricing · 3 Jan 2026 · 0 likes Cost per milligram is the only comparison that survives format differences, but even then it needs care. A pen and a vial are not the same product and cannot be…
Selection into a registry and what it does to the estimate Replied, post #3 · Evidence › Study critique · 1 Jan 2026 · 7 likes Worth separating two things that the opening post runs together. Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random…
How to ask about something you suspect is a bad idea Replied, post #38 · Start Here › How to Ask · 27 Dec 2025 · 15 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #77 · Compounds › Semaglutide · 25 Dec 2025 · 25 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #3 · Evidence › Journal club · 16 Dec 2025 · 0 likes post #2 is right about the mechanism and I think understates the practical bit. SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg.…
Coming back to: Why most self-reports here are not experiments, and that is fine Replied, post #18 · Research Methods › N-of-1 designs · 10 Nov 2025 · 32 likes When to run an n-of-1: this design works when you want to know whether a treatment works for you, not whether it works in general. For that purpose, it is efficient.
What pooling buys you and what it destroys Replied, post #51 · Evidence › Meta-analyses · 26 Oct 2025 · 0 likes When a meta-analysis is unhelpful: if the included studies are heterogeneous in population, intervention, or outcome, pooling them produces a number that represents…
NHS criteria and how they are applied in practice — the long version Replied, post #10 · Regional › UK & Ireland · 11 Oct 2025 · 0 likes On post #6 — agreed on the reasoning, with one qualification. Cross-border arrangements: some people source from other EU countries. Rules on import for personal use…
Insurance and replacement policies, compared — the long version Replied, post #18 · Sourcing › Logistics · 22 Sep 2025 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #130 · Wellbeing › Mental health · 10 Sep 2025 · 14 likes post #129 is right about the mechanism and I think understates the practical bit. Identity and self-image: for some people, weight and body size are central to…
Aggregated purity results across four services, with caveats — a second dataset Replied, post #85 · Data & Tools › Datasets · 9 Sep 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #24 · Compounds › Other compounds · 21 Aug 2025 · 22 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
Coming back to: A community side-effect dataset, with its response rate and biases Started this topic · Data & Tools › Datasets · 8 Jul 2025 · 0 likes On the subject in the title: A community side-effect dataset, with its response rate and biases Working notes rather than a conclusion. Posting the method first,…
Follow-up: Documentation that appears only after payment Replied, post #64 · Sourcing › Red flags · 10 May 2025 · 1 like On post #60 — agreed on the reasoning, with one qualification. Patterns that reliably precede a problem: underdosing (less active material than stated, documented by…
Ipamorelin selectivity claims and where they came from Replied, post #33 · Compounds › Secretagogues & GH axis · 30 Apr 2025 · 17 likes This follows post #30 rather than contradicting it. Secretagogues and glucose tolerance: there is a mechanistic concern that sustained growth hormone elevation might…
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #14 · Evidence › Journal club · 29 Apr 2025 · 17 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
UK access routes, dated and sourced — a second dataset Replied, post #67 · Regional › UK & Ireland · 22 Apr 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Requesting a page: what makes a good request Replied, post #49 · Documentation › Wiki requests · 8 Apr 2025 · 21 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #17 · Access › Pricing · 24 Mar 2025 · 18 likes Insurance tier placement: a compound might be covered but on a higher tier (higher copay). Moving to a lower tier usually requires prior authorization or documented…
Research-use-only labelling: what it means and what it does not — the long version Replied, post #108 · Sourcing › Regulatory · 18 Mar 2025 · 29 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
Maintainer handover: how it works Replied, post #30 · Meta › Wiki maintenance · 15 Mar 2025 · 0 likes Maintainer handovers: if a page's maintainer is inactive and needs a new one, discussing that here can facilitate the transition.
Reading an MS report that only gives you a single number Replied, post #25 · Analytics › Mass spectrometry · 9 Mar 2025 · 6 likes post #24 answers the question as asked. The question underneath it is different. Tandem mass spectrometry: MS/MS fragments the molecular ion and uses fragment masses to…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #12 · Sourcing › Regulatory · 27 Feb 2025 · 0 likes I read post #10 twice before replying, because I had assumed the opposite. Why this category is maintained as documentation, not as recommendations: the goal is factual…
Distinguishing a deletion sequence by mass alone Replied, post #122 · Analytics › Mass spectrometry · 23 Feb 2025 · 0 likes I read post #120 twice before replying, because I had assumed the opposite. Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is…
Follow-up: What other technical communities get right that we do not Replied, post #22 · Lounge › Off topic · 21 Feb 2025 · 0 likes post #21 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
Biased agonism: a real phenomenon, an over-used explanation — what changed since Replied, post #52 · Pharmacology › Receptor biology · 15 Feb 2025 · 0 likes Pharmacological class effects: all GLP-1 agonists slow gastric emptying and suppress appetite. Those are class effects, not unique to one compound. Effects that differ…
Protein density versus volume when you cannot eat much Replied, post #59 · Nutrition & Training › Protein & intake · 2 Feb 2025 · 10 likes Worth separating two things that post #55 runs together. Leucine and MPS: leucine stimulates muscle protein synthesis at a threshold of roughly 2 to 3 grams per meal.…
When to suspect the method rather than the sample Replied, post #73 · Analytics › Method validation · 28 Jan 2025 · 22 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
SURPASS-2 and the comparator dose question that will not go away Replied, post #108 · Compounds › Tirzepatide · 18 Jan 2025 · 3 likes Worth separating two things that post #104 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
Recovery when intake is low: what to cut first Replied, post #17 · Nutrition & Training › Resistance training · 10 Jan 2025 · 32 likes Frequency: three sessions per week of full-body training is easier to maintain than higher frequencies on an energy deficit. Consistency beats intensity when recovery…
A promotion I argued against, and why I lost Replied, post #47 · Documentation › Doc review · 1 Jan 2025 · 9 likes Picking up post #44: that is the part I would want checked first. Evidence synthesis requests: if you think a page should summarise the state of evidence on a question,…
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #42 · Practice › Interactions · 28 Dec 2024 · 10 likes Sulfonylureas and meglitinides: these agents stimulate insulin release and carry hypoglycemia risk. Combining them with semaglutide or tirzepatide requires dose…
The topic list is dense — is that deliberate? Replied, post #71 · Meta › Site feedback · 23 Dec 2024 · 0 likes Navigation problems: if you cannot find something you expected to exist, or the path to it is unclear, report it. Site architecture affects usability.
Identical chromatograms across two different lots Replied, post #64 · Sourcing › Red flags · 19 Dec 2024 · 1 like Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…
[2026 update] Step therapy requirements and how to satisfy them Replied, post #67 · Access › Insurance & coverage · 13 Dec 2024 · 16 likes I read post #65 twice before replying, because I had assumed the opposite. Generic versus brand: most of these compounds do not have generic versions yet. Once they do,…
Tirzepatide storage and stability: what is published versus what is assumed — does this… Replied, post #12 · Compounds › Tirzepatide · 3 Dec 2024 · 4 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #8 · Data & Tools › Calculators · 1 Dec 2024 · 14 likes Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat: "equivalence" is not precise and individual response varies.…
Coming back to: When to suspect the method rather than the sample Replied, post #8 · Analytics › Method validation · 29 Nov 2024 · 6 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #37 · Compounds › Semaglutide · 21 Nov 2024 · 26 likes On alcohol: the labelling does not contraindicate it, but it raises gastric irritation risk and semaglutide already does that. There is no published interaction study…
EMA product information as a primary source — does this still hold? Replied, post #53 · Regional › European Union · 16 Nov 2024 · 20 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Promotion criteria, and the one that stops most nominations Replied, post #92 · Documentation › Doc review · 22 Oct 2024 · 6 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
Guidelines revision: what changed and why Replied, post #72 · Meta › Announcements · 27 Jul 2024 · 27 likes Coming back to post #70, because the follow-up matters more than the original answer. Feedback to announcements: if you have feedback on an announced change (not a…
Follow-up: Conditions that change the calculus rather than forbidding it Replied, post #7 · Safety › Contraindications · 15 Jul 2024 · 0 likes Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential benefits. Planning windows and washout (several months) are the…
The mass-error checker and its intended scope Replied, post #57 · Data & Tools › Calculators · 17 Jun 2024 · 9 likes Offline use: all calculators are written in JavaScript and can be downloaded and run offline if desired. They do not require internet connectivity to function.